Across rheumatic diseases

Trends in avascular necrosis and related arthroplasties in hospitalized patients with systemic lupus erythematosus and rheumatoid arthritis

Semin Arthritis RheumPublished Cross-sectional study

Authors' conclusion

We report a breakpoint in rising SLE-AVN after 2011, which may relate to newer steroid-sparing therapies (i.e., belimumab). AVN-associated arthroplasties decreased in SLE and RA. Fewer AVN-associated arthroplasties were noted for Black patients and those with Medicaid, indicating potential disparities.

Study context

Population
Hospitalized adults with systemic lupus erythematosus (SLE) and RA, U.S. National Inpatient Sample 2000–2019, identified by ICD codes
Participants
42,728 vs 43,600
Exposure
SLE vs RA hospitalizations, with or without avascular necrosis (AVN)
  • SLE-AVNn = 42,728
  • RA-AVNn = 43,600
Outcome
AVN and AVN-related arthroplasty rates and time trends (APC) in SLE and RA
Methodological detailsU.S. National Inpatient Sample (2000-2019), Joinpoint regression
  • U.S. National Inpatient Sample (2000-2019)
  • Joinpoint regression

Main finding

As reported in the abstract

AVN and AVN-related arthroplasty rates and trends
GroupValueArthroplastiesAVN annual percent change (APC) 2000-2011AVN APC 2011-2019Arthroplasty APCAVN APC
SLE-AVN1.3 %16,724 (39 %)1.94*−2.03−2.03*
RA-AVN0.5 %25,210 (58 %)−0.82*0.98*

Value

SLE-AVN1.3 %
RA-AVN0.5 %

Arthroplasties

SLE-AVN16,724 (39 %)
RA-AVN25,210 (58 %)

AVN annual percent change (APC) 2000-2011

SLE-AVN1.94*
RA-AVN— not stated in the abstract

AVN APC 2011-2019

SLE-AVN−2.03
RA-AVN— not stated in the abstract

Arthroplasty APC

SLE-AVN−2.03*
RA-AVN−0.82*

AVN APC

SLE-AVN— not stated in the abstract
RA-AVN0.98*

Observational data: associations, not effects.

Further findings

Characteristics of AVN hospitalizations and arthroplasties

AVN hospitalizations: younger and of Black race
Arthroplasties less likely in Black race or Medicaid coverage

Original publication

Trends in avascular necrosis and related arthroplasties in hospitalized patients with systemic lupus erythematosus and rheumatoid arthritis. Semin Arthritis Rheum. Published 10 April 2024. doi:10.1016/j.semarthrit.2024.152444

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.